Basel Medical Group Income Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Revenue	10.05	9.7	10.66
Other Revenue	0.02	0.05	-
Revenue	10.07	9.75	10.66
Revenue Growth (YoY)	3.32%	-8.55%	-
Cost of Revenue	5.89	5.58	2.72
Gross Profit	4.18	4.16	7.94
Selling, General & Admin	0.7	1.05	5.78
Other Operating Expenses	0.81	0.55	-0.31
Operating Expenses	2.04	2.16	5.48
Operating Income	2.14	2	2.46
Interest Expense	-0.18	-0.24	-0.32
Interest & Investment Income	-	0.3	0.25
Other Non Operating Income (Expenses)	0.44	0.07	-
Pretax Income	2.4	2.13	2.39
Income Tax Expense	0.33	0.35	0.41
Net Income	2.07	1.78	1.98
Net Income to Common	2.07	1.78	1.98
Net Income Growth	16.23%	-9.84%	-
Shares Outstanding (Basic)	16	16	16
Shares Outstanding (Diluted)	16	16	16
EPS (Basic)	0.13	0.11	0.12
EPS (Diluted)	0.13	0.11	0.12
EPS Growth	16.23%	-9.84%	-
Free Cash Flow	2.5	2.59	2.7
Free Cash Flow Per Share	0.15	0.16	0.17
Gross Margin	41.54%	42.71%	74.48%
Operating Margin	21.24%	20.55%	23.09%
Profit Margin	20.58%	18.30%	18.56%
Free Cash Flow Margin	24.84%	26.61%	25.37%
EBITDA	2.17	2.03	2.48
EBITDA Margin	21.54%	20.86%	23.30%
D&A For EBITDA	0.03	0.03	0.02
EBIT	2.14	2	2.46
EBIT Margin	21.24%	20.55%	23.09%
Effective Tax Rate	13.80%	16.34%	17.12%

Updated Nov 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q